Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 367-371, January 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galffy, G.
Right arrow Articles by Antony, V. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galffy, G.
Right arrow Articles by Antony, V. B.
[Cancer Research 59, 367-371, January 15, 1999]
© 1999 American Association for Cancer Research


Carcinogenesis

Interleukin 8

An Autocrine Growth Factor for Malignant Mesothelioma

Gabriella Galffy, Kamal A. Mohammed, Patrick A. Dowling, Najmunnisa Nasreen, Melissa J. Ward and Veena B. Antony1

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Veterans’ Affairs Medical Center, Indiana University School of Medicine, Indianapolis, Indiana 46202

Interleukin 8 (IL-8) is a potent chemokine that also has a direct growth-potentiating effect on certain tumors. In the present study, we determined IL-8 levels in human malignant mesothelioma (MM) effusions and congestive heart failure pleural fluids. We also investigated antigenic IL-8 production by different MM cell lines, and we describe the role of IL-8 in the autocrine growth regulation of MMs. Mesothelial (CRL-9444 = MC) and MM (CRL-2081 = MM-1, CRL-5915 = MM-2, and CRL-5820 = MM-3) cell lines were grown using standard culture methods. The bioactive IL-8 levels were measured in supernatants of cultured cells by ELISA, and the expression of cell-associated immunoreactive IL-8 was observed by immunohistochemistry. The proliferative activity was determined by thymidine ([3H]thymidine) incorporation and also by direct cell counts after incubation with varying concentrations of IL-8 in the presence/absence of specific polyclonal IL-8 antibody. We found significantly higher levels of IL-8 in mesothelioma pleural fluids than congestive heart failure and a time-dependent increase in IL-8 levels in MM-1 and MM-2 cell supernatants during 96 h of incubation. IL-8 levels were nearly undetectable in MM-3 and MC cell line supernatants. In MM-1 and MM-2 cells, IL-8 caused a dose-dependent increase of [3H]thymidine incorporation to maximal levels of 46.3 ± 3.6% and 12.3 ± 1.6% (P < 0.001), respectively, when compared with serum-free medium as control. Neutralization of IL-8 significantly decreased proliferative activity of MM-1 and MM-2. IL-8 did not induce proliferative activity in MM-3 and MC cells. We conclude that IL-8 had a direct growth-potentiating activity in MMs.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
H. I. Pass, G. J. Brewer, R. Dick, M. Carbone, and S. Merajver
A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results.
Ann. Thorac. Surg., August 1, 2008; 86(2): 383 - 389.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. H. Benoy, R. Salgado, P. Van Dam, K. Geboers, E. Van Marck, S. Scharpe, P. B. Vermeulen, and L. Y. Dirix
Increased Serum Interleukin-8 in Patients with Early and Metastatic Breast Cancer Correlates with Early Dissemination and Survival
Clin. Cancer Res., November 1, 2004; 10(21): 7157 - 7162.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Catania, G. Colombo, A. Carlin, L. Garofalo, S. Gatti, R. Buffa, N. Carboni, L. Rosso, L. Santambrogio, L. Cantalamessa, et al.
Autocrine inhibitory influences of {alpha}-melanocyte-stimulating hormone in malignant pleural mesothelioma
J. Leukoc. Biol., February 1, 2004; 75(2): 253 - 259.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. M. Mian, C. P. N. Dinney, C. E. Bermejo, P. Sweeney, C. Tellez, X. D. Yang, J. M. Gudas, D. J. McConkey, and M. Bar-Eli
Fully Human Anti-Interleukin 8 Antibody Inhibits Tumor Growth in Orthotopic Bladder Cancer Xenografts via Down-Regulation of Matrix Metalloproteases and Nuclear Factor-{kappa}B
Clin. Cancer Res., August 1, 2003; 9(8): 3167 - 3175.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Huang, L. Mills, B. Mian, C. Tellez, M. McCarty, X.-D. Yang, J. M. Gudas, and M. Bar-Eli
Fully Humanized Neutralizing Antibodies to Interleukin-8 (ABX-IL8) Inhibit Angiogenesis, Tumor Growth, and Metastasis of Human Melanoma
Am. J. Pathol., July 1, 2002; 161(1): 125 - 134.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
B. T. Mossman and D. C. Gruenert
SV40, Growth Factors, and Mesothelioma . Another Piece of the Puzzle
Am. J. Respir. Cell Mol. Biol., February 1, 2002; 26(2): 167 - 170.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
A. S. Haqqani, J. K. Sandhu, and H.C. Birnboim
Constitutive expression of interleukin-8 by Mutatect cells markedly affects their tumor biology
Carcinogenesis, February 1, 2001; 22(2): 243 - 250.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Q. Shi, J. L. Abbruzzese, S. Huang, I. J. Fidler, Q. Xiong, and K. Xie
Constitutive and Inducible Interleukin 8 Expression by Hypoxia and Acidosis Renders Human Pancreatic Cancer Cells More Tumorigenic and Metastatic
Clin. Cancer Res., November 1, 1999; 5(11): 3711 - 3721.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.